ANDREA PETRI: Open Payments
NPI 1366910747 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,607 in 130 payments from 34 companies in 2025. Trend: 2023 $898 · 2024 $979 · 2025 $2,607
Food & beverage: $2,607
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $238 |
| GlaxoSmithKline, LLC. | 13 | $231 |
| Daiichi Sankyo Inc. | 7 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $156 |
| Merck Sharp & Dohme LLC | 10 | $153 |
| TerSera Therapeutics LLC | 6 | $150 |
| SERVIER PHARMACEUTICALS LLC | 5 | $133 |
| Janssen Biotech, Inc. | 6 | $128 |
| Immunocore Limited | 1 | $127 |
| Eisai Inc. | 8 | $126 |
Products named: JEMPERLI, Zoladex, Fabhalta, KIMMTRAK, Lenvima, DATROWAY, KEYTRUDA, KISQALI.
Industry payments across FL — which companies pay providers there.
